Clinical data of non-diabetic and diabetic patients
| Non-diabetic (n = 83) | Diabetic (n = 83) | p Value | |
|---|---|---|---|
| *Twice the upper limit of the authors’ laboratory. | |||
| Median age (years) | 71 | 71 | 1.000 |
| Female sex | 26 (31.3%) | 26 (31.3%) | 1.000 |
| Hypertension | 36 (43.4%) | 39 (47.0%) | 0.640 |
| Smoking history | 43 (51.8%) | 27 (32.5%) | 0.012 |
| Hypercholesterolaemia | 46 (55.4%) | 47 (56.6%) | 0.876 |
| Body mass index ⩾25 kg/m2 | 49 (59.0%) | 52 (62.7%) | 0.633 |
| Stable angina >3 months before admission | 22 (26.5%) | 31 (37.3%) | 0.134 |
| Previous myocardial infarction | 22 (26.5%) | 24 (28.9%) | 0.729 |
| Aspirin at admission | 31 (37.3%) | 26 (31.3%) | 0.414 |
| Statins at admission | 13 (15.7%) | 10 (12.0%) | 0.500 |
| ⩾2 anginal episodes in previous 24 hours | 37 (44.6%) | 28 (33.7%) | 0.152 |
| ⩾ST segment depression ⩾0.5 mm at admission | 38 (45.8%) | 46 (55.4%) | 0.214 |
| Coronary angiography during the study | 39 (47.0%) | 34 (41.0%) | 0.434 |
| One vessel disease | 13 (66.7%) | 8 (23.5%) | 0.356 |
| Multivessel disease | 26 (33.3%) | 26 (76.5%) | 0.356 |
| Troponin I ⩾0.2 ng/ml at admission* | 32 (38.6%) | 29 (34.9%) | 0.629 |
| Mean (SD) time from onset of chest pain to admission (hours) | 4.7 (3.0) | 4.6 (3.3) | 0.785 |
| Median C reactive protein (mg/l) | 5 (2, 8) | 7 (3, 11) | 0.020 |
| Median fibrinogen (g/l) | 2.90 (2.44, 3.33) | 3.34 (2.62, 3.92) | 0.013 |
| Median leucocyte (×109/l) | 7.8 (6.5, 10.1) | 8.8 (6.9, 11.3) | 0.040 |